Tumour budding in colorectal cancer: what do we know and what can we do? (Q38650462)

5 September 2017

title

Tumour budding in colorectal cancer: what do we know and what can we do? (English)

1 reference

5 September 2017

1 reference

1 reference

Linde De Smedt

1

1 reference

5 September 2017

Sofie Palmans

series ordinal

2

1 reference

5 September 2017

Xavier Sagaert

series ordinal

3

1 reference

5 September 2017

language of work or name

1 reference

27 November 2015

1 reference

5 September 2017

1 reference

5 September 2017

volume

468

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

397-408

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-015-1886-5

5 September 2017

exact match

0 references

cites work

An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Quantification of tumour budding, lymphatic vessel density and invasion through image analysis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Tumour budding: a promising parameter in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Tumor budding as an index to identify high-risk patients with stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Tumor budding and survival after potentially curative resection of node-positive colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Role of epithelial-mesenchymal transition in gastric cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Molecular mechanisms of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

TGF-beta-induced epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Evolution of colorectal cancer: change of pace and change of direction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Assessment of tumor budding in colorectal carcinoma: correlation with β-catenin nuclear expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1886-5

Prognostic value of tumor "budding" in patients with colorectal cancer

21 January 2018

1 reference

12 December 2020

Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

1 reference

12 December 2020

Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers

1 reference

12 December 2020

Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study

1 reference

12 December 2020

Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma

1 reference

12 December 2020

TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.

1 reference

12 December 2020

Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin

1 reference

12 December 2020

Mucinous differentiation in colorectal cancer--indicator of poor prognosis?

1 reference

12 December 2020

Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.

1 reference

12 December 2020

Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma

1 reference

12 December 2020

High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer

1 reference

12 December 2020

Budding Is Useful to Select High-Risk Patients in Stage II Well-Differentiated or Moderately Differentiated Colon Adenocarcinoma

1 reference

12 December 2020

Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

1 reference

12 December 2020

Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer

1 reference

12 December 2020

Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer

1 reference

12 December 2020

Role of APAF-1, E-cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer

1 reference

12 December 2020

MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC)

1 reference

12 December 2020

Molecular and pathogenetic aspects of tumor budding in colorectal cancer

1 reference

12 December 2020

Tumour budding as prognostic factor in stage I/II colorectal carcinoma

1 reference

12 December 2020

Pathological predictors for lymph node metastasis in T1 colorectal cancer

1 reference

12 December 2020

Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma

1 reference

12 December 2020

Loss of membranous Ep-CAM in budding colorectal carcinoma cells

1 reference

12 December 2020

Biological significance of tumor budding at the invasive front of human colorectal carcinoma cells

1 reference

12 December 2020

Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia

1 reference

12 December 2020

Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer

1 reference

12 December 2020

Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status

1 reference

12 December 2020

10.1007/S00428-015-1886-5

Identifiers

DOI

1 reference

5 September 2017

1 reference